Overview

* Nordson Corp ( NDSN ) fiscal Q3 sales rise 12% yr/yr, beating analyst expectations, per LSEG data

* Adjusted EPS for fiscal Q3 increases 13%, surpassing analyst estimates, per LSEG data

* Company authorizes new $500 mln share repurchase

Outlook

* Nordson ( NDSN ) expects full-year sales slightly below midpoint of original guidance

* Company anticipates full-year adjusted EPS slightly above midpoint of guidance

* Nordson's ( NDSN ) full-year outlook supported by pending divestiture completion

* Company maintains full-year sales and earnings guidance after strong Q3

Result Drivers

* ACQUISITION IMPACT - Sales growth driven by 8% favorable acquisition impact, notably from Atrion acquisition

* TECHNOLOGY GROWTH - Advanced Technology Solutions segment achieved 15% organic sales growth, driven by electronics dispense product lines

* MEDICAL SEGMENT - Medical and Fluid Solutions sales rose 32%, largely due to acquisition impact, with organic growth in medical fluid components

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $741.51 $723.10

mln mln (9

Analysts

)

Q3 Beat $2.73 $2.64 (8

Adjusted Analysts

EPS )

Q3 EPS $2.22

Q3 Net $125.78

Income mln

Q3 Gross 54.8%

Margin

Q3 $187.77

Operatin mln

g Profit

Q3 $159.12

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

* Wall Street's median 12-month price target for Nordson Corp ( NDSN ) is $249.66, about 12.9% above its August 19 closing price of $217.50

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 19 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)